[
1. Atkins C., Bonagura J., Ettinger S., Fox P., Gordon S., Haggstrom J., Hamlin R., Keene B., Luis-Fuentes V., Stepien R.: ACVIM consensus statement, guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med 2009, 23, 1142-1150.10.1111/j.1939-1676.2009.0392.x19780929
]Search in Google Scholar
[
2. Aupperle H., Thielebein J., Kiefer B., Marz I., Dinges G., Schoon H.A.: An immunohistchemical study of the role of matrix metalloproteinases and their tissue inhibitor in chronic mitral valvular diease (valvular endocardiosis) in dogs. Vet J 2009, 180, 88-94.10.1016/j.tvjl.2007.11.01118295518
]Search in Google Scholar
[
3. Aupperle H., Thielebein J., Kiefer B., Marz I., Dinges G., Schoon H.A., Schubert A.: Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves. J Comp Pathol 2009, 140, 271-277.10.1016/j.jcpa.2009.01.00119285315
]Search in Google Scholar
[
4. Disatian S., Ehrhart E.J., Zimmerman S., Orton E.C.: Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation. J Heart Valve Dis 2008, 17, 402-412.
]Search in Google Scholar
[
5. Garncarz M., Jank M., Łój M., Parzeniecka-Jaworska M.: A retrospective study of clinical signs and epidemiology of chronic valve disease in a group of 207 Dachshunds in Poland. Acta Vet Scand 2013, 2013, 55, 52, doi:10.1186/1751-0147-55-52.10.1186/1751-0147-55-52372388423844824
]Search in Google Scholar
[
6. Garncarz M., Parzeniecka-Jaworska M., Łój M., Jank M. The use of peripheral blood nucleated cells for the transcriptomic characterization of heart disease in dogs. In: BSAVA Congress Proceedings. Gloucester 2013, 580.
]Search in Google Scholar
[
7. Hautala N., Tokola H., Luodonpää M., Puhakka J., Romppanen H., Vuolteenaho O., Ruskoaho H.: Pressure overload increases GATA4 binding activity via endothelin-1. Circulation 2001, 103, 730-735.10.1161/01.CIR.103.5.730
]Search in Google Scholar
[
8. Kiczak L., Tomaszek A., Bania J., Pasławska U., Zacharski M., Noszczyk-Nowak A., Janiszewski A., Skrzypczak P., Ardehali H., Jankowska E.A., Ponikowski P.: Expression and complex formation of MMP9, MMP2, NGAL, and TIMP1 in porcine myocardium but not in skeletal muscles in male pigs with tachycardia-induced systolic heart failure. BioMed Res Int, vol. 2013, Article ID 283856, doi: 10.1155/2013/283856.10.1155/2013/283856365465923710440
]Search in Google Scholar
[
9. Lee J.S., Pak S.I., Hyun C.: Calcium reuptake related genes as a cardiac biomarker in dogs with chronic mitral valvular insufficiency. J Vet Intern Med 2009, 23, 832-839.10.1111/j.1939-1676.2009.0332.x19496905
]Search in Google Scholar
[
10. Lemon D.D., Horn T.R., Cavasin M.A., Jeong M.Y., Haubold K.R., Long Carlin S.L., Irwin D.C., McCune S.A., Chung E., Leinwand L.A., McKinsey T.A.: Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. J Mol Cell Cardiol 2011, 51, 41-50.10.1016/j.yjmcc.2011.04.005311352621539845
]Search in Google Scholar
[
11. Liu P.Y., Death A.K., Handelsman D.J.: Androgens and cardiovascular disease. Endocr Rev 2003, 24, 313-340.10.1210/er.2003-000512788802
]Search in Google Scholar
[
12. Łój M., Garncarz M., Jank M.: Genomic and genetic aspects of heart failure in dogs - a review. Acta Vet Hung 2012, 60, 17-26.10.1556/avet.2012.00222366129
]Search in Google Scholar
[
13. Moon H.S., Choi E., Hyun C.: The cardiac sodium-calcium exchanger gene (NCX-1) is a potential canine cardiac biomarker of chronic mitral valvular insufficiency. J Vet Intern Med 2008, 22, 1360-1365.10.1111/j.1939-1676.2008.0209.x
]Search in Google Scholar
[
14. Musunuru K.: Cell-specific RNA-binding proteins in human disease. Trends Cardiovasc Med 2003, 13, 188-195.10.1016/S1050-1738(03)00075-6
]Search in Google Scholar
[
15. Na S.J., Han S.H., Kim H.W., Hyun C.: The cardiac biomarker sodium-calcium Exchange (NCX-1) can differentiate between heart failure and renal failure: a comparative study of NCX-1 expression in dogs with chronic mitral valvular insufficiency and azotemia. J Vet Intern Med 2010, 24, 1383-1387.10.1111/j.1939-1676.2010.0628.x21054542
]Search in Google Scholar
[
16. Obayashi K., Miyagawa-Tomita S., Matsumoto H., Koyama H., Nakanishi T., Hirose H., Effects of transforming growth factor- ß3 and matrix metalloproteinase-3 on the pathogenesis of chronic mitral valvular disease in dogs. Am J Vet Res 2011, 72, 194-202.10.2460/ajvr.72.2.19421281193
]Search in Google Scholar
[
17. Olsen L.H., Fredholm M., Pdersen H.D.: Epidemiology and inheritance of mitral valve prolapsed in Dachshunds. J Vet Intern Med 1999, 13, 448-456.10.1111/j.1939-1676.1999.tb01462.x
]Search in Google Scholar
[
18. Oyama M.A., Chittur S.V.: Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease. Am J Vet Res 2006, 67, 1307-1318.10.2460/ajvr.67.8.130716881841
]Search in Google Scholar
[
19. Parker H.G., Kilroy-Glynn P.: Myxomatous mitral valve disease in dogs: does size matter? J Vet Cardiol 2012, 14, 19-29.10.1016/j.jvc.2012.01.006330789422356836
]Search in Google Scholar
[
20. Pasławska U., Noszczyk-Nowak A., Nicpoń J.: An assessment of left ventricular systoli function with the use of a continuous Doppler imaging in dogs with spontaneous mitral regurgitation. A preliminary study. Bull Vet Inst Pulawy 2012, 56, 399-402.10.2478/v10213-012-0070-9
]Search in Google Scholar
[
21. Rush J.E. Canine chronic valvular heart disease: pathology and pathogenesis. In: Proceedings of the American College of Veterinary Internal Medicine - Cardiology Forum, 2004, 58.
]Search in Google Scholar
[
22. Stanley W.C., Recchia F.A., Lopaschuk G.D.: Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005, 85, 1093-1129.10.1152/physrev.00006.200415987803
]Search in Google Scholar
[
23. Van Hemelrijck M., Garmo H., Holmberg L., Ingelsson E., Bratt O., Bill-Axelson A., Lambe M., Stattin P., Adolfsson J.: Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the population-based PCBaSe Sweden. J Clin Oncol 2010, 28, 3448-3456.10.1200/JCO.2010.29.156720567006
]Search in Google Scholar
[
24. Van Loon J.E., Leebeek F.W.G., Deckers J.W., Dippel D.W.J., Poldermans D., Strachan D.P., Tang W., O’Donnell C.J., Smith N.L., De Maat M.P.M.: Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk. Circ Cardiovasc Genet 2010, 3, 507-512.10.1161/CIRCGENETICS.110.957407351183721156930
]Search in Google Scholar
[
25. Zheng J., Chen Y., Pat B., Dell’italia L.A., Tillson M., Dillon A.R., Powell P.C., Shi K., Shah N., Denney T., Husain A., Dell’Italia L.J.: Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog. Circulation 2009, 119, 2086-2095.10.1161/CIRCULATIONAHA.108.826230309237019349319
]Search in Google Scholar
